435 related articles for article (PubMed ID: 12101276)
1. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation.
Takaki H; Minoda Y; Koga K; Takaesu G; Yoshimura A; Kobayashi T
Genes Cells; 2006 Aug; 11(8):871-82. PubMed ID: 16866871
[TBL] [Abstract][Full Text] [Related]
4. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
5. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
7. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
8. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
Han Y; Zhou ZH; Ransohoff RM
J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice.
Nakabayashi T; Letterio JJ; Geiser AG; Kong L; Ogawa N; Zhao W; Koike T; Fernandes G; Dang H; Talal N
J Immunol; 1997 Jun; 158(11):5527-35. PubMed ID: 9164977
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells.
Banu N; Meyers CM
Kidney Int; 1999 Sep; 56(3):985-94. PubMed ID: 10469366
[TBL] [Abstract][Full Text] [Related]
13. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages.
Maffei A; Scarpellino L; Bernard M; Carra G; Jotterand-Bellomo M; Guardiola J; Accolla RS
J Immunol; 1987 Aug; 139(3):942-8. PubMed ID: 3110290
[TBL] [Abstract][Full Text] [Related]
14. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
[TBL] [Abstract][Full Text] [Related]
15. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
[TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
Doukas J; Pober JS
J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
[TBL] [Abstract][Full Text] [Related]
18. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
20. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]